UAEM Netherlands Pushes For Clinical Trial Transparency

On June 20th, Universities Allied for Essential Medicines Netherlands (UAEM NL) called upon the General Secretary of the Central Committee on Research Involving Human Subjects (CCMO) to address concerns regarding clinical trial transparency within the country.

This initiative garnered support from various allied organizations, including Health Action International, Doctors Without Borders the Netherlands, Wemos, and TranspariMED.

The CCMO is currently undergoing the reform of the Dutch National Trial Registry. As health advocacy organizations, we are eager to contribute to this pivotal effort aimed at enhancing the prompt registration and reporting of results for all clinical trials conducted in the Netherlands and eagerly anticipate engaging in productive discussions with the CCMO.

Previous
Previous

UAEM North America Urges Senate HELP Committee to support Reasonable Pricing

Next
Next

UAEM ED Quoted in the People’s Dispatch